Originator Organization POP Biotechnologies, Inc.Startup |
Active Organization- |
Inactive Organization POP Biotechnologies, Inc.Startup |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | US | POP Biotechnologies, Inc.Startup | 17 Nov 2021 |